These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3138085)

  • 21. Immunofluorescent staining method for use with monoclonal antibodies.
    Costanzo C; Raza A
    Cell Biochem Funct; 1984 Jul; 2(3):153-4. PubMed ID: 6383651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical demonstration of S-phase cells in bladder tumors by anti-bromodeoxyuridine monoclonal antibody. Using in vitro labeling method].
    Tsujihashi H; Matsuda H; Akiyama T; Kurita T; Uejima S
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):423-7. PubMed ID: 3221593
    [No Abstract]   [Full Text] [Related]  

  • 25. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
    Cheitlin RA; Bodell WJ
    Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
    Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
    Wien Klin Wochenschr; 1985 Nov; 97(22):850-5. PubMed ID: 4082602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of adriamycin on the cell cycle by bromodeoxyuridine-labeling method].
    Tenjin T
    Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1623-32. PubMed ID: 3193010
    [No Abstract]   [Full Text] [Related]  

  • 28. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine.
    Thornton JG; Wells M; Hume WJ
    J Pathol; 1988 Apr; 154(4):321-8. PubMed ID: 3385512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double labeling of human leukemic cells using 3H-cytarabine and monoclonal antibody against bromodeoxyuridine.
    Raza A; Preisler HD
    Cancer Treat Rep; 1985 Feb; 69(2):195-8. PubMed ID: 3882228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in the DNA metabolism of MCa-11 mouse mammary tumor cells grown in vivo and in vitro.
    Allison DC; Anderson S; Ridolpho PF; Meyne J; Robertson J
    Cancer Res; 1986 Aug; 46(8):3951-7. PubMed ID: 3731066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrochloric acid denaturation of colorectal tumour tissue infiltrated with bromodeoxyuridine.
    Williamson K; Gilliland R; Weir H; Grimes J; Hamilton P; Anderson N; Crockard A; Rowlands B
    Cytometry; 1994 Feb; 15(2):162-8. PubMed ID: 8168403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of S-phase fractions measured by flow cytometry and autoradiography in human transplant tumors.
    Feichter G; Czech W; Haag D; Goerttler K; Futterman G; Loehrke H; Abel U
    Cytometry; 1988 Nov; 9(6):605-11. PubMed ID: 3208626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine].
    Miyamoto H; Isobe H; Ito M; Mizuno S; Kawakami Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3541-5. PubMed ID: 3789763
    [No Abstract]   [Full Text] [Related]  

  • 36. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of proportion of S-phase cells in ascites and pleural effusions in ovarian carcinoma using antibromodeoxyuridine monoclonal antibody and DNA flow-cytometry.
    Sahni K; Tribukait B; Einhorn N
    Acta Oncol; 1989; 28(5):705-8. PubMed ID: 2590547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.